Datamonitor's Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
Contains an executive summary and data on value, volume and segmentation
Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
Incorporates in-depth five forces competitive environment analysis and scorecards
Compares data from the US, Canada and Mexico, alongside individual chapters on each country. .
Includes a five-year forecast of the industry
Highlights
The NAFTA pharmaceuticals market reaches a value of $303.5 billion in 2007.
The US is the leading country among the NAFTA bloc, with market revenues of $271.2 billion in 2007
Mexico was the fastest growing country, with a CAGR of 10.2% over the 2004-2007 period.
Why you should buy this report
Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
(0 items)
